CapsoVisionCV
CV logo
Fair Value
US$14
Share price11 Jan
US$6.6152.8% undervalued intrinsic discount
Loading
1Y57.76%
7D-12.33%

AI Capsule Endoscopy And Pancreatic Screening Will Transform Long Term Prospects

Analyst High Target compiles bullish analysts opinions to create narratives which represent one standard deviation above the consensus price target, using forecasted revenue and earnings figures, as well as the transcripts of earnings calls

Published
11 Jan 26
Views
8
Not Invested

Fair Value vs Share Price

US$14
vs US$6.6152.8% undervalued intrinsic discount
PastFuture-21m77m2023202420252026202720282029Revenue US$76.9mEarnings US$9.0m
80.4%
Revenue growth
11.7%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on CapsoVision

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Adequate balance sheet with low risk.

Market capUS$363.7m
PB16.3x
Estimated Growth27.2%
Dividend YieldN/A
Full analysis

CEO & management

Kang-Huai Wang
CEO
9.8yrs
CEO Tenure

A medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system.